Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Sep-24 4:17 PM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Aug-24 | Grant | 647 | $8.69 | $5,622.43 | < 1% 74.69K to 75.33K | |
| 14-Jun-24 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 10% 67.87K to 74.69K | |
| 04-Jun-24 4:30 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-24 | Option Exercise | 4,660 | -- | -- | 59% 7.86K to 12.52K | |
| 03-Jun-24 4:29 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-24 | Grant | 870 | $6.46 | $5,620.20 | 1% 67.0K to 67.87K | |
| 22-May-24 7:21 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-May-24 | Private Purchase | 15,000 | $6.25 | $93,750.00 | 29% 52.0K to 67.0K | |
| 04-Mar-24 5:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-24 | Grant | 999 | $5.63 | $5,624.37 | 2% 51.0K to 52.0K | |
| 01-Dec-23 4:42 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-23 | Grant | 956 | $5.88 | $5,621.28 | 2% 50.04K to 51.0K | |
| 05-Sep-23 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-23 | Grant | 791 | $7.11 | $5,624.01 | 2% 49.25K to 50.04K | |
| 11-Aug-23 4:30 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 10-Aug-23 | Sale | 3,283 | $0.53 | $1,750.17 | (27%) 12.27K to 8.99K | |
| 15-Jun-23 4:35 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 52% 32.51K to 49.25K | |
| 05-Jun-23 5:08 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jun-23 | Option Exercise | 4,507 | -- | -- | 134% 3.36K to 7.86K | |
| 02-Jun-23 4:36 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-23 | Grant | 680 | $8.27 | $5,623.60 | 2% 31.83K to 32.51K | |
| 02-Mar-23 4:44 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-23 | Grant | 635 | $8.85 | $5,619.75 | 2% 31.19K to 31.83K | |
| 02-Dec-22 6:28 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-22 | Grant | 421 | $13.36 | $5,624.56 | 1% 30.77K to 31.19K | 11% |
| 02-Sep-22 4:36 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-22 | Grant | 404 | $13.90 | $5,615.60 | 1% 30.37K to 30.77K | 6% |
| 09-Jun-22 4:51 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Jun-22 | Grant | 12,866 | -- | -- | 74% 17.5K to 30.37K | |
| 06-Jun-22 5:24 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Jun-22 | Option Exercise | 3,356 | -- | -- | 100% 0 to 3.36K | |
| 24-Nov-21 6:35 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 24-Nov-21 | Market Purchase | 7,500 | $12.19 | $91,425.00 | 75% 10.0K to 17.5K | 1% |
| 12-Jan-21 7:00 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 12-Jan-21 | Market Sale | 3,210 | $4.20 | $13,474.30 | (2%) 211.82K to 208.61K | 73% |
| 11-Jan-21 8:09 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 05-Jan-21 | Market Sale | 2,740 | $3.91 | $10,700.00 | (1%) 214.56K to 211.82K | 71% |
| 22-Dec-20 6:45 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 22-Dec-20 | Market Sale (Planned) | 37,169 | $4.32 | $160,525.00 | (15%) 251.73K to 214.56K | 74% |
| 22-Dec-20 6:45 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 18-Dec-20 | Grant | 128,170 | -- | -- | 104% 123.56K to 251.73K | |
| 14-Jan-20 6:19 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 10-Jan-20 | Grant | 37,000 | -- | -- | 43% 86.56K to 123.56K | |
| 10-Jan-20 8:14 AM View: | Idera Pharmaceuticals, Inc. (ACGN) | 07-Jan-20 | Market Sale | 3,006 | $1.78 | $5,351.88 | (3%) 89.57K to 86.56K | 36% |
| 17-Dec-19 4:49 PM View: | Spark Therapeutics, Inc. (ONCE) | 17-Dec-19 | Disposition (change in control) | 3,000 | $114.50 | $343,500.00 | (100%) 3.0K to 0 | |
| 03-Jun-19 4:17 PM View: | Spark Therapeutics, Inc. (ONCE) | 30-May-19 | Option Exercise | 1,500 | -- | -- | 100% 1.5K to 3.0K | |
| 07-Jan-19 8:11 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 03-Jan-19 | Grant | 33,750 | -- | -- | 60% 55.82K to 89.57K | |
| 26-Dec-18 9:21 AM View: | Idera Pharmaceuticals, Inc. (ACGN) | 24-Dec-18 | Market Purchase | 15,000 | $2.93 | $43,923.00 | 37% 40.82K to 55.82K | (61%) |
| 08-Aug-18 7:35 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 07-Aug-18 | Market Purchase | 10,000 | $5.51 | $55,100.00 | 32% 30.82K to 40.82K | (79%) |
| 15-Jun-18 4:30 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 13-Jun-18 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 31-May-18 9:32 PM View: | Spark Therapeutics, Inc. (ONCE) | 31-May-18 | Option Exercise | 1,500 | -- | -- | 100% 0 to 1.5K | |
| 19-Jun-17 5:10 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Jun-17 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 17-Mar-16 8:23 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 15-Mar-16 | Market Purchase | 40,000 | $1.97 | $78,800.00 | 19% 206.53K to 246.53K | (93%) |
| 15-Dec-14 5:01 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 12-Dec-14 | Market Purchase | 200,000 | $4.00 | $799,100.00 | 100% 0 to 200.0K | (96%) |
| 28-Jan-14 8:29 PM View: | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 311,798 | -- | -- | 65% 482.28K to 794.08K | |
| 28-Jan-14 8:29 PM View: | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 311,798 | -- | -- | (39%) 794.08K to 482.28K | |
| 28-Jan-14 8:29 PM View: | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 482,281 | $50.00 | $24,114,000.00 | (100%) 482.28K to 0 | < 1% |
| 21-Jan-14 11:41 AM View: | ViroPharma Inc. (VPHM) | 17-Jan-14 | Option Exercise | 79,126 | $8.67 | $686,214.00 | 20% 403.15K to 482.28K | |
| 07-Jan-14 4:08 PM View: | ViroPharma Inc. (VPHM) | 06-Jan-14 | Option Exercise | 40,309 | $3.55 | $143,097.00 | 11% 362.85K to 403.15K | |
| 20-Dec-13 4:08 PM View: | ViroPharma Inc. (VPHM) | 18-Dec-13 | Payment of Exercise | 337,810 | $49.74 | $16,802,700.00 | (48%) 700.66K to 362.85K | (< 1%) |
| 20-Dec-13 4:08 PM View: | ViroPharma Inc. (VPHM) | 18-Dec-13 | Option Exercise | 586,310 | $10.78 | $6,317,880.00 | 513% 114.35K to 700.66K | |
| 30-Nov-12 4:17 PM View: | ViroPharma Inc. (VPHM) | 28-Nov-12 | Option Exercise | 18,000 | $3.55 | $63,900.00 | 19% 94.42K to 112.42K | |
| 13-Nov-12 4:06 PM View: | ViroPharma Inc. (VPHM) | 08-Nov-12 | Option Exercise | 83,418 | $4.53 | $378,273.00 | 88% 94.42K to 177.83K | |
| 13-Nov-12 4:06 PM View: | ViroPharma Inc. (VPHM) | 08-Nov-12 | Market Option Sale | 83,418 | $24.54 | $2,047,330.00 | (47%) 177.83K to 94.42K | (103%) |
| 06-Jan-12 4:10 PM View: | ViroPharma Inc. (VPHM) | 04-Jan-12 | Payment of Exercise | 7,224 | $27.91 | $201,622.00 | (7%) 101.61K to 94.38K | (78%) |
| 06-Jan-12 4:10 PM View: | ViroPharma Inc. (VPHM) | 04-Jan-12 | Option Exercise | 10,000 | $27.91 | $279,100.00 | 11% 91.61K to 101.61K | 78% |
| 06-Dec-11 4:13 PM View: | ViroPharma Inc. (VPHM) | 05-Dec-11 | Option Exercise | 15,005 | $2.09 | $31,366.70 | 20% 76.21K to 91.21K | |
| 23-Nov-11 4:03 PM View: | ViroPharma Inc. (VPHM) | 21-Nov-11 | Option Exercise | 76,687 | $3.36 | $257,937.00 | 101% 76.21K to 152.9K | |
| 23-Nov-11 4:03 PM View: | ViroPharma Inc. (VPHM) | 21-Nov-11 | Market Option Sale (Planned) | 76,687 | $22.53 | $1,727,440.00 | (50%) 152.9K to 76.21K | (121%) |
| 15-Dec-10 4:56 PM View: | ViroPharma Inc. (VPHM) | 13-Dec-10 | Payment of Exercise | 6,272 | $16.89 | $105,934.00 | (8%) 80.66K to 74.39K | (199%) |